Role of auto- and allotransplantation in B-cell chronic lymphocytic leukemia.
Although important progress has been made in its management, B-cell chronic lymphocytic leukemia (CLL) remains incurable with standard therapies. Hematopoietic stem-cell transplants (HSCT) are frequently being offered to individuals with CLL, the hope being that, as in other hematologic malignancies, they can prolong survival in or even cure some patients. This article analyzes which patients with CLL are appropriate candidates for HSCT, current transplant procedures, results with autologous and allogeneic HSCT, and future trends in transplantation in this form of leukemia.
Institute of Hematology and Oncology, Hospital Clinic, c/ Villarroel, 170-08036 Barcelona, Spain. emontse@clinic.ub.es
Emili
E
Montserrat
D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D012008:Recurrence; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous